An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer
Clinical trial NCT00113607 · COMPLETED
Trial details
- NCT number
- NCT00113607
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2010-11-01
- Enrollment
- 672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.